News & Events

April 4, 2011

IntegriChain Launches Channel Research Center

INTEGRICHAIN EXPANDS OPERATIONS AND TECHNOLOGY FACILITIES TO SUPPORT CONTINUED GROWTH

Princeton, NJ – April 4, 2011 – IntegriChain, Inc., a next-generation life sciences informatics company, today opened its new operations center in Princeton.

The new facility will house IntegriChain’s customer service and engineering teams, as well as its significantly expanded Channel Research Center. The Channel Research Center, the first of its kind, is dedicated to real time monitoring of the U.S. healthcare supply chain, prescription drug inventory research, and support services for IntegriChain’s gold standard channel master data services.

The Channel Research Center will include a call center initially staffed with two dozen research professionals, and will be responsible for maintaining the channel data customer masters for ten of the fifteen largest global drug makers, as well as many mid-tier and emerging pharma companies. IntegriChain’s channel customer master service, DNA: Channel Sales, includes the integration of pharmacies, hospitals, physicians’ practices, distributors, GPOs, payers and plans to a common set of identifiers and authoritative name, address, class of trade, and affiliation information.

“Manufacturers can’t unlock their channel data’s value without robust master data management and data quality assurance,” stated Dennis O’Malley, IntegriChain’s VP of Customer Operations. “The Channel Research Center shows IntegriChain’s expanding commitment to making wholesale and specialty data ready to support commercial use.”

In conjunction with the new facility, IntegriChain’s production systems have been relocated to hardened, redundant facilities in Bethlehem and Valley Forge, Pennsylvania. The new data centers are supporting IntegriChain’s recent addition of more than two dozen manufacturers to its flagship product offering, DNA: Dynamic NextGen Analytics®, as well as IntegriChain’s continued success in meeting customer audit requirements.

About IntegriChain
IntegriChain, Inc. launched the Demand Network Analytics (DNA) commerce platform in 2007. Today, DNA is helping a growing community of innovative manufacturers realize their vision of a truly demand driven enterprise. DNA’s trade data management and analytic applications optimize hundreds of billions of dollars in annual commerce, helping manufacturers lower their distribution costs, improve sales predictability, and ensure product availability throughout their distribution channels. For more information, please visit www.integrichain.com.

All names referred to are trademarks or registered trademarks of their respecitve owners.

adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand